4ABV - JenaLib

Asym./Biol. Unit (Jmol Viewer)

Asym./Biol. Unit - sites (Jmol Viewer)

Title :   CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-3

Authors :   D. Tomar, T. Khan, R. R. Singh, S. Mishra, S. Gupta, A. Surolia, D. M. Salu

Date :   11 Dec 11 (Deposition) - 26 Sep 12 (Release) - 26 Sep 12 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   1.80

Chains :   Asym./Biol. Unit : A,B

Keywords :   Transport Protein, Hormone, Amyloidosis Inhibition (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   D. Tomar, T. Khan, R. R. Singh, S. Mishra, S. Gupta, A. Surolia, D. M. Salunke
Crystallographic Study Of Novel Transthyretin Ligands Exhibiting Negative-Cooperativity Between Two Thyroxine Binding Sites.
Plos One V. 7 43522 2012
PubMed-ID: 22973437 | Reference-DOI: 10.1371/JOURNAL.PONE.0043522

Molecule 1 - TRANSTHYRETIN
	Chains	:	A, B
	Engineered	:	YES
	Expression System	:	ESCHERICHIA COLI
	Expression System Taxid	:	562
	Expression System Vector	:	PMMHA
	Expression System Vector Type	:	PLASMID
	Fragment	:	RESIDUES 21-144
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	ATTR, PREALBUMIN, TBPA

		1	2
Asymmetric/Biological Unit	:	A	B

Summary Information (see also Sequences/Alignments below)

Asymmetric/Biological Unit (1, 2)

No.	Name	Count	Type	Full Name
1	FT2	2	Ligand/Ion	5-(CHLOROMETHYL)-2-(2,4-DICHLOROPHENOXY)PHENOL

Asymmetric Unit (2, 2)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	LYS A:15 , LEU A:17 , THR A:106 , ALA A:108 , ALA A:109 , LEU A:110 , SER A:117 , THR A:118 , THR A:119	BINDING SITE FOR RESIDUE FT2 A1125
2	AC2	SOFTWARE	LYS B:15 , LEU B:17 , ALA B:108 , ALA B:109 , LEU B:110 , SER B:117 , THR B:118 , THR B:119	BINDING SITE FOR RESIDUE FT2 B1125

(no "SS Bond" information available for 4ABV)

Asymmetric/Biological Unit

No.	Residues
1	Gly A:101	-	Pro A:102

Asymmetric/Biological Unit (86, 172)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_007547	C	30	R	TTHY_HUMAN	Disease (AMYL-TTR)	121918083	A/B	C	10	R
02	UniProt	VAR_038959	L	32	P	TTHY_HUMAN	Disease (AMYL-TTR)	121918094	A/B	L	12	P
03	UniProt	VAR_038960	M	33	I	TTHY_HUMAN	Polymorphism	---	A/B	M	13	I
04	UniProt	VAR_007548	D	38	E	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	D	18	E
05	UniProt	VAR_007549	D	38	G	TTHY_HUMAN	Disease (AMYL-TTR)	121918098	A/B	D	18	G
06	UniProt	VAR_007550	V	40	I	TTHY_HUMAN	Disease (AMYL-TTR)	121918093	A/B	V	20	I
07	UniProt	VAR_038961	S	43	N	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	S	23	N
08	UniProt	VAR_007551	P	44	S	TTHY_HUMAN	Disease (AMYL-TTR)	11541790	A/B	P	24	S
09	UniProt	VAR_010658	V	48	M	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	V	28	M
10	UniProt	VAR_007552	V	50	A	TTHY_HUMAN	Disease (AMYL-TTR)	79977247	A/B	V	30	A
11	UniProt	VAR_038962	V	50	G	TTHY_HUMAN	Disease (AMYL-TTR)	79977247	A/B	V	30	G
12	UniProt	VAR_007553	V	50	L	TTHY_HUMAN	Disease (AMYL-TTR)	28933979	A/B	V	30	L
13	UniProt	VAR_007554	V	50	M	TTHY_HUMAN	Disease (AMYL-TTR)	28933979	A/B	V	30	M
14	UniProt	VAR_038963	F	53	C	TTHY_HUMAN	Unclassified	---	A/B	F	33	C
15	UniProt	VAR_007555	F	53	I	TTHY_HUMAN	Disease (AMYL-TTR)	121918068	A/B	F	33	I
16	UniProt	VAR_007556	F	53	L	TTHY_HUMAN	Disease (AMYL-TTR)	121918068	A/B	F	33	L
17	UniProt	VAR_038964	F	53	V	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	F	33	V
18	UniProt	VAR_038965	R	54	T	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	R	34	T
19	UniProt	VAR_038966	K	55	N	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	K	35	N
20	UniProt	VAR_007557	A	56	P	TTHY_HUMAN	Disease (AMYL-TTR)	121918077	A/B	A	36	P
21	UniProt	VAR_038967	D	58	A	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	D	38	A
22	UniProt	VAR_038968	D	58	V	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	D	38	V
23	UniProt	VAR_038969	W	61	L	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	W	41	L
24	UniProt	VAR_038970	E	62	D	TTHY_HUMAN	Disease (AMYL-TTR)	11541796	A/B	E	42	D
25	UniProt	VAR_007558	E	62	G	TTHY_HUMAN	Disease (AMYL-TTR)	11541796	A/B	E	42	G
26	UniProt	VAR_038971	F	64	S	TTHY_HUMAN	Disease (AMYL-TTR)	104894665	A/B	F	44	S
27	UniProt	VAR_007559	A	65	D	TTHY_HUMAN	Disease (AMYL-TTR)	730881169	A/B	A	45	D
28	UniProt	VAR_038972	A	65	S	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	A	45	S
29	UniProt	VAR_007560	A	65	T	TTHY_HUMAN	Disease (AMYL-TTR)	121918078	A/B	A	45	T
30	UniProt	VAR_007561	G	67	A	TTHY_HUMAN	Disease (AMYL-TTR)	121918090	A/B	G	47	A
31	UniProt	VAR_038973	G	67	E	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	G	47	E
32	UniProt	VAR_007562	G	67	R	TTHY_HUMAN	Disease (AMYL-TTR)	387906523	A/B	G	47	R
33	UniProt	VAR_007563	G	67	V	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	G	47	V
34	UniProt	VAR_007564	T	69	A	TTHY_HUMAN	Disease (AMYL-TTR)	121918081	A/B	T	49	A
35	UniProt	VAR_038974	T	69	I	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	T	49	I
36	UniProt	VAR_007565	S	70	I	TTHY_HUMAN	Disease (AMYL-TTR)	121918080	A/B	S	50	I
37	UniProt	VAR_007566	S	70	R	TTHY_HUMAN	Disease (AMYL-TTR)	386134269	A/B	S	50	R
38	UniProt	VAR_007567	S	72	P	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	S	52	P
39	UniProt	VAR_038975	G	73	E	TTHY_HUMAN	Disease (AMYL-TTR)	121918097	A/B	G	53	E
40	UniProt	VAR_007568	E	74	G	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	E	54	G
41	UniProt	VAR_038976	E	74	K	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	E	54	K
42	UniProt	VAR_007569	L	75	P	TTHY_HUMAN	Disease (AMYL-TTR)	121918079	A/B	L	55	P
43	UniProt	VAR_038977	L	75	Q	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	L	55	Q
44	UniProt	VAR_007570	L	78	H	TTHY_HUMAN	Disease (AMYL-TTR)	121918069	A/B	L	58	H
45	UniProt	VAR_007571	L	78	R	TTHY_HUMAN	Disease (AMYL-TTR)	121918069	A/B	L	58	R
46	UniProt	VAR_007572	T	79	K	TTHY_HUMAN	Disease (AMYL-TTR)	730881163	A/B	T	59	K
47	UniProt	VAR_007573	T	80	A	TTHY_HUMAN	Disease (AMYL-TTR)	121918070	A/B	T	60	A
48	UniProt	VAR_038978	E	81	G	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	E	61	G
49	UniProt	VAR_007574	E	81	K	TTHY_HUMAN	Disease (AMYL-TTR)	121918086	A/B	E	61	K
50	UniProt	VAR_007575	F	84	L	TTHY_HUMAN	Disease (AMYL-TTR)	121918091	A/B	F	64	L
51	UniProt	VAR_007576	I	88	L	TTHY_HUMAN	Disease (AMYL-TTR)	121918085	A/B	I	68	L
52	UniProt	VAR_007577	Y	89	H	TTHY_HUMAN	Disease (AMYL-TTR)	121918100	A/B	Y	69	H
53	UniProt	VAR_007578	K	90	N	TTHY_HUMAN	Disease (AMYL-TTR)	267607160	A/B	K	70	N
54	UniProt	VAR_007579	V	91	A	TTHY_HUMAN	Disease (AMYL-TTR)	121918084	A/B	V	71	A
55	UniProt	VAR_007580	I	93	V	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	I	73	V
56	UniProt	VAR_007581	D	94	H	TTHY_HUMAN	Polymorphism	730881164	A/B	D	74	H
57	UniProt	VAR_007582	S	97	Y	TTHY_HUMAN	Disease (AMYL-TTR)	121918071	A/B	S	77	Y
58	UniProt	VAR_038979	Y	98	F	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	Y	78	F
59	UniProt	VAR_007583	I	104	N	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	I	84	N
60	UniProt	VAR_007584	I	104	S	TTHY_HUMAN	Disease (AMYL-TTR)	121918072	A/B	I	84	S
61	UniProt	VAR_038980	I	104	T	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	I	84	T
62	UniProt	VAR_010659	E	109	K	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	E	89	K
63	UniProt	VAR_007585	E	109	Q	TTHY_HUMAN	Disease (AMYL-TTR)	121918082	A/B	E	89	Q
64	UniProt	VAR_007586	H	110	N	TTHY_HUMAN	Polymorphism	121918074	A/B	H	90	N
65	UniProt	VAR_007587	A	111	S	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	A	91	S
66	UniProt	VAR_038981	V	114	A	TTHY_HUMAN	Unclassified	---	A/B	V	94	A
67	UniProt	VAR_007588	A	117	G	TTHY_HUMAN	Disease (AMYL-TTR)	121918087	A/B	A	97	G
68	UniProt	VAR_038982	A	117	S	TTHY_HUMAN	Disease (AMYL-TTR)	267607161	A/B	A	97	S
69	UniProt	VAR_007589	G	121	S	TTHY_HUMAN	Polymorphism	755337715	A/B	G	101	S
70	UniProt	VAR_007590	P	122	R	TTHY_HUMAN	Polymorphism	---	A/B	P	102	R
71	UniProt	VAR_007591	R	124	C	TTHY_HUMAN	Polymorphism	745834030	A/B	R	104	C
72	UniProt	VAR_038983	R	124	H	TTHY_HUMAN	Polymorphism	121918095	A/B	R	104	H
73	UniProt	VAR_038984	T	126	N	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	T	106	N
74	UniProt	VAR_038985	I	127	M	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	I	107	M
75	UniProt	VAR_007592	I	127	V	TTHY_HUMAN	Disease (AMYL-TTR)	121918089	A/B	I	107	V
76	UniProt	VAR_007593	A	129	T	TTHY_HUMAN	Disease (DTTRH)	267607159	A/B	A	109	T
77	UniProt	VAR_007594	L	131	M	TTHY_HUMAN	Disease (AMYL-TTR)	121918073	A/B	L	111	M
78	UniProt	VAR_007595	Y	134	C	TTHY_HUMAN	Disease (AMYL-TTR)	121918075	A/B	Y	114	C
79	UniProt	VAR_007598	Y	134	H	TTHY_HUMAN	Disease (CTS1)	121918088	A/B	Y	114	H
80	UniProt	VAR_007596	Y	136	S	TTHY_HUMAN	Disease (AMYL-TTR)	730881167	A/B	Y	116	S
81	UniProt	VAR_007597	Y	136	V	TTHY_HUMAN	Unclassified	---	A/B	Y	116	V
82	UniProt	VAR_007599	T	139	M	TTHY_HUMAN	Polymorphism	28933981	A/B	T	119	M
83	UniProt	VAR_038986	A	140	S	TTHY_HUMAN	Disease (AMYL-TTR)	876658108	A/B	A	120	S
84	UniProt	VAR_038987	V	142	A	TTHY_HUMAN	Disease (AMYL-TTR)	---	A/B	V	122	A
85	UniProt	VAR_007600	V	142	I	TTHY_HUMAN	Disease (AMYL-TTR)	28933980	A/B	V	122	I
86	UniProt	VAR_038988	N	144	S	TTHY_HUMAN	Disease (AMYL-TTR)	144965179	A/B	N	124	S

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric/Biological Unit (2, 4)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	TRANSTHYRETIN_1	PS00768	Transthyretin signature 1.	TTHY_HUMAN	35-50	2	A:15-30 B:15-30
2	TRANSTHYRETIN_2	PS00769	Transthyretin signature 2.	TTHY_HUMAN	125-137	2	A:105-117 B:105-117

Asymmetric/Biological Unit (3, 6)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000237014	1a	ENSE00001836564	chr18:29171689-29171934	246	TTHY_HUMAN	1-23	23	0	-	-
1.2	ENST00000237014	2	ENSE00000796938	chr18:29172859-29172989	131	TTHY_HUMAN	24-67	44	2	A:10-47 B:10-47	38 38
1.3a	ENST00000237014	3a	ENSE00000796939	chr18:29175083-29175218	136	TTHY_HUMAN	67-112	46	2	A:47-92 B:47-92	46 46
1.8a	ENST00000237014	8a	ENSE00001827041	chr18:29178531-29178974	444	TTHY_HUMAN	113-147	35	2	A:93-124 B:93-124	32 32

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:115
 aligned with TTHY_HUMAN | P02766 from UniProtKB/Swiss-Prot  Length:147

    Alignment length:115
                                    39        49        59        69        79        89        99       109       119       129       139     
           TTHY_HUMAN    30 CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN 144
               SCOP domains d4abva_ A: Transthyretin (synonym: prealbumin)                                                                      SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeeeee....ee....eeeeeee.....eeeeeeee.....ee...........eeeeeeehhhhhhhh......eeeeeeeeee........................... Sec.struct. author
             SAPs(SNPs) (1) R-PI----E-I--NS---M-A--CTNP-A--LD-SD-A-AI-PEGP--HKAG--L---LHNA-VH--YF-----N----KNS--A--G---SR-C-NM-T-M--C-S--MS-A-S SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------G-----------G--I----V---G--S-E-IR---KQ--R--K----------------------S----Q-------S------H--V------H-V-----I-- SAPs(SNPs) (2)
             SAPs(SNPs) (3) --------------------L--L-----------T-R------------------------------------T---------------------------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) --------------------M--V-------------V----------------------------------------------------------------------------- SAPs(SNPs) (4)
                    PROSITE -----TRANSTHYRETIN_1 --------------------------------------------------------------------------TRANSTHYRETIN------- PROSITE
           Transcript 1 (1) Exon 1.2  PDB: A:10-47 UniProt: 24-67 ---------------------------------------------Exon 1.8a  PDB: A:93-124         Transcript 1 (1)
           Transcript 1 (2) -------------------------------------Exon 1.3a  PDB: A:47-92 UniProt: 67-112       -------------------------------- Transcript 1 (2)
                 4abv A  10 CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN 124
                                    19        29        39        49        59        69        79        89        99       109       119

Chain B from PDB  Type:PROTEIN  Length:115
 aligned with TTHY_HUMAN | P02766 from UniProtKB/Swiss-Prot  Length:147

    Alignment length:115
                                    39        49        59        69        79        89        99       109       119       129       139     
           TTHY_HUMAN    30 CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN 144
               SCOP domains d4abvb_ B: Transthyretin (synonym: prealbumin)                                                                      SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeeeee....ee....eeeeeee.....eeeeeeee.....ee...........eeeeeeehhhhhhhh......eeeeeeeeee........................... Sec.struct. author
             SAPs(SNPs) (1) R-PI----E-I--NS---M-A--CTNP-A--LD-SD-A-AI-PEGP--HKAG--L---LHNA-VH--YF-----N----KNS--A--G---SR-C-NM-T-M--C-S--MS-A-S SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------G-----------G--I----V---G--S-E-IR---KQ--R--K----------------------S----Q-------S------H--V------H-V-----I-- SAPs(SNPs) (2)
             SAPs(SNPs) (3) --------------------L--L-----------T-R------------------------------------T---------------------------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) --------------------M--V-------------V----------------------------------------------------------------------------- SAPs(SNPs) (4)
                    PROSITE -----TRANSTHYRETIN_1 --------------------------------------------------------------------------TRANSTHYRETIN------- PROSITE
           Transcript 1 (1) Exon 1.2  PDB: B:10-47 UniProt: 24-67 ---------------------------------------------Exon 1.8a  PDB: B:93-124         Transcript 1 (1)
           Transcript 1 (2) -------------------------------------Exon 1.3a  PDB: B:47-92 UniProt: 67-112       -------------------------------- Transcript 1 (2)
                 4abv B  10 CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN 124
                                    19        29        39        49        59        69        79        89        99       109       119

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric/Biological Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: All beta proteins (24004)

Fold: Prealbumin-like (433)

Superfamily: Transthyretin (synonym: prealbumin) (211)

Family: Transthyretin (synonym: prealbumin) (198)

Protein domain: Transthyretin (synonym: prealbumin) (194)

Human (Homo sapiens) [TaxId: 9606] (184)

1a	d4abva_	A:
1b	d4abvb_	B:

(no "CATH Domain" information available for 4ABV)

(no "Pfam Domain" information available for 4ABV)

Asymmetric/Biological Unit(hide GO term definitions)

Chain A,B (TTHY_HUMAN | P02766)

molecular function
	GO:0005179	hormone activity	The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process.
	GO:0042562	hormone binding	Interacting selectively and non-covalently with any hormone, naturally occurring substances secreted by specialized cells that affect the metabolism or behavior of other cells possessing functional receptors for the hormone.
	GO:0042802	identical protein binding	Interacting selectively and non-covalently with an identical protein or proteins.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0046982	protein heterodimerization activity	Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
biological process
	GO:0044267	cellular protein metabolic process	The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
	GO:0030198	extracellular matrix organization	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
	GO:0001523	retinoid metabolic process	The chemical reactions and pathways involving retinoids, any member of a class of isoprenoids that contain or are derived from four prenyl groups linked head-to-tail. Retinoids include retinol and retinal and structurally similar natural derivatives or synthetic compounds, but need not have vitamin A activity.
	GO:0042572	retinol metabolic process	The chemical reactions and pathways involving retinol, one of the three compounds that makes up vitamin A.
	GO:0006810	transport	The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter, pore or motor protein.
cellular component
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0043234	protein complex	A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.

Asymmetric/Biological Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		FT2	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Gly A:101 - Pro A:102	[ RasMol ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym./Biol. Unit PNG format \| Asym./Biol. Unit - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	4abv
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	TTHY_HUMAN \| P02766
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	(no 'Enzyme Classificator' available)
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	105210
		Disease Information	:	OMIM
	115430
		Disease Information	:	OMIM
	145680
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	TTHY_HUMAN \| P02766
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

1bm7	HUMAN TRANSTHYRETIN (PREALBUMIN) COMPLEX WITH FLUFENAMIC ACID (2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID)
1bmz	HUMAN TRANSTHYRETIN (PREALBUMIN)
1bz8	TRANSTHYRETIN (DEL VAL122)
1bzd	TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION
1bze	TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION
1dvq	CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN
1dvs	CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH RESVERATROL
1dvt	CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH FLURBIPROFEN
1dvu	CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DIBENZOFURAN- 4,6-DICARBOXYLIC ACID
1dvx	CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DICLOFENAC
1dvy	CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH N-( M- TRIFLUOROMETHYLPHENYL) PHENOXAZINE-4,6-DICARBOXYLIC ACID
1dvz	CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH O- TRIFLUOROMETHYLPHENYL ANTHRANILIC ACID
1e3f	STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING
1e4h	STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING
1e5a	STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING
1eta	TRANSTHYRETIN (PREALBUMIN) NATURALLY OCCURRING VARIANT WITH 1:1 MIX OF VAL AND MET AT POSITION 30 COMPLEXED WITH THYROXINE (3,5,3',5'-TETRAIODO-L-THYRONINE)
1etb	TRANSTHYRETIN (PREALBUMIN) MUTANT WITH ALA 109 REPLACED BY THR (A109T) COMPLEXED WITH THYROXINE (3,5,3',5'- TETRAIODO-L-THYRONINE)
1f41	CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN AT 1.5A RESOLUTION
1f64	LEU55PRO TTR-IDOX THEORETICAL MODEL
1f86	TRANSTHYRETIN THR119MET PROTEIN STABILISATION
1fh2	TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIS
1fhn	TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIS
1g1o	CRYSTAL STRUCTURE OF THE HIGHLY AMYLOIDOGENIC TRANSTHYRETINMUTANT TTR G53S/E54D/L55S
1gko	AN ENGINEERED TRANSTHYRETIN MONOMER THAT IS NON- AMYLOIDOGENIC - UNLESS PARTIALLY DENATURED
1ict	MONOCLINIC FORM OF HUMAN TRANSTHYRETIN COMPLEXED WITHTHYROXINE (T4)
1iii	CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C -DATA COLLECTED AT ROOM TEMPERATURE
1iik	CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C -DATA COLLECTED AT CRYO TEMPERATURE
1ijn	CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR C10A/ Y114C
1qab	THE STRUCTURE OF HUMAN RETINOL BINDING PROTEIN WITH ITSCARRIER PROTEIN TRANSTHYRETIN REVEALS INTERACTION WITH THECARBOXY TERMINUS OF RBP
1qwh	A COVALENT DIMER OF TRANSTHYRETIN THAT AFFECTS THE AMYLOIDPATHWAY
1rlb	RETINOL BINDING PROTEIN COMPLEXED WITH TRANSTHYRETIN 1RLB 3
1sok	CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT A108Y/ L110ESOLVED IN SPACE GROUP P21212
1soq	CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT A108Y/ L110ESOLVED IN SPACE GROUP C2
1tha	TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3,3 '-DIIODO-L-THYRONINE
1thc	TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3',5 '-DIBROMO-2',4,4',6-TETRA-HYDROXYAURONE
1tlm	TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH MILRINONE
1tsh	TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION
1tt6	THE ORTHORHOMBIC CRYSTAL STRUCTURE OF TRANSTHYRETIN INCOMPLEX WITH DIETHYLSTILBESTROL
1tta	TRANSTHYRETIN (FORMERLY PREALBUMIN)
1ttb	TRANSTHYRETIN (FORMERLY PREALBUMIN) MUTANT WITH ALA 109 REPLACED BY THR (A109T)
1ttc	TRANSTHYRETIN (FORMERLY PREALBUMIN) MUTANT WITH VAL 30 REPLACED BY MET (V30M)
1ttr	TRANSTHYRETIN - V/122/I CARDIOMYOPATHIC MUTANT
1tyr	TRANSTHYRETIN COMPLEX WITH RETINOIC ACID
1tz8	THE MONOCLINIC CRYSTAL STRUTURE OF TRANSTHYRETIN IN COMPLEXWITH DIETHYLSTILBESTROL
1u21	TRANSTHYRETIN WITH TETHERED INHIBITOR ON ONE MONOMER.
1x7s	THE X-RAY CRYSTALLOGRAPHIC STRUCTURE OF THE AMYLOIDOGENICVARIANT TTR TYR78PHE
1x7t	STRUCTURE OF TTR R104H: A NON-AMYLOIDOGENIC VARIANT WITHPROTECTIVE CLINICAL EFFECTS
1y1d	CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITHIODODIFLUNISAL
1z7j	HUMAN TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3,3',5,5'-TETRAIODOTHYROACETIC ACID (T4AC)
1zcr	CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN WITH BOUND IODIDE
1zd6	CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN WITH BOUND CHLORIDE
2b14	THE CRYSTAL STRUCTURE OF 2,4-DINITROPHENOL IN COMPLEX WITHTHE AMYLOIDOGENIC VARIANT TRANSTHYRETIN LEU 55 PRO
2b15	THE CRYSTAL STRUCTURE OF 2,4-DINITROPHENOL IN COMPLEX WITHHUMAN TRANSTHYRETIN
2b16	THE CRYSTAL STRUCTURE OF 2,4-DINITROPHENOL IN COMPLEX WITHTHE AMYLOIDOGENIC VARIANT TRANSTHYRETIN TYR78PHE
2b77	HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH DIFLUNISALANALOGUES - TTR.2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3- CARBOXYLIC ACID
2b9a	HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH DIFLUNISALANALOGUES - TTR.3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID
2f7i	HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH DIFLUNISALANALOGUES - TTR. 2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID
2f8i	HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH BENZOXAZOLE
2fbr	HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH BIVALANT AMYLOIDINHIBITOR (4 CORBON LINKER)
2flm	HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH BIVALANT AMYLOIDINHIBITOR (6 CARBON LINKER)
2g5u	HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH HYDROXYLATEDPOLYCHLORINATED BIPHENYL-4,4'-DIHYDROXY-3,3', 5,5'-TETRACHLOROBIPHENYL
2g9k	HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH HYDROXYLATEDPOLYCHLORINATED BIPHENYL-4-HYDROXY-2',3,3',4 ',5-PENTACHLOROBIPHENYL
2gab	HUMAN TRANSTHYRETIN (TTR) COMPLEXED WITH HYDROXYLATEDPOLYCHLORINATED BIPHENYL-4-HYDROXY-3,3',5,4 '-TETRACHLOROBIPHENYL
2pab	PREALBUMIN (HUMAN PLASMA)
2rox	TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH THYROXINE (T4)
2roy	TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3',5 '-DINITRO-N-ACETYL-L-THYRONINE
2trh	TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION
2try	TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION
2wqa	COMPLEX OF TTR AND RBP4 AND OLEIC ACID
4abq	CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-1
4abu	CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-2
4abw	CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-6
4ac2	CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-7
4ac4	CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-18
4act	CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-17
4ank	CRYSTALLOGRAPHIC STUDY OF NOVEL TRANSTHYRETIN LIGANDS EXHIBITING NEGATIVE-COOPERATIVITY BETWEEN TWO T4 BINDING SITES.
5ttr	LEU 55 PRO TRANSTHYRETIN CRYSTAL STRUCTURE

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (1, 2)

Sites (2, 2)

SS Bonds (0, 0)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (86, 172)

PROSITE Motifs (2, 4)

Exons (3, 6)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 2)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (15, 15)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File